MedTrace Logo

Impact of Fever Prevention in Brain Injured Patients

NCT02996266 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 686

Last updated 2023-09-21

Study results available
· View outcomes & findings →

Summary

This study will assess the impact of fever prevention on fever burden and short- and long-term neurologic outcomes in brain injured patients. Half of the subjects will undergo fever prevention using a targeted temperature management system and half of the subjects will be treated for fever should it develop.

Conditions

Interventions

DEVICE

Targeted Temperature Management

Prophylactic normothermia

OTHER

Standard Care

No intervention to control temperature unless fever occurs

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Boston University

    collaborator OTHER

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • David M. Greer, MD, MA · Boston University

  • Kevin N. Sheth, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-05-12
Completion
2022-05-12

Countries

  • United States
  • Australia
  • Austria
  • Germany
  • South Korea
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02996266 on ClinicalTrials.gov